Sarcopenia: Origins and Clinical Relevance

1997/05/01 by Irwin H. Rosenberg · 37 citations
Medicine · #Nutrition and Health in Aging #Body Composition Measurement Techniques

paper · pdf · doi:10.1093/jn/127.5.990s

Cited by

• Two Weeks of Reduced Activity Decreases Leg Lean Mass and Induces “Anabolic Resistance” of Myofibrillar Protein Synthesis in Healthy Elderly
• A Neurogenic Perspective of Sarcopenia: Time Course Study of Sciatic Nerves From Aging Mice
• Sarcopenia, osteoporosis and frailty
• Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia
• Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle
• Assessment of methods of evaluating sarcopenia in old dogs
• Reproducibility of jumping mechanography and traditional measures of physical and muscle function in older adults
• Skeletal Muscle: A Brief Review of Structure and Function
• Getting to the heart of sarcopenia and cardiovascular disease
• Osseous manifestations of sarcoidosis
• Associations of Creatinine Muscle Index with markers of sarcopenia and mortality in chronic kidney disease: A prospective cohort study
• Quantification of skeletal muscle mass: sarcopenia as a marker of overall health in children and adults
• Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. [europepmc]
• Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. [europepmc]
• Sarcopenia: diagnosis and treatment. [europepmc]
• Molecular inflammation: underpinnings of aging and age-related diseases. [europepmc]
• Sarcopenic obesity: definition, cause and consequences. [europepmc]
• Mechanical signals as anabolic agents in bone. [europepmc]
• Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. [europepmc]
• Sarcopenia with limited mobility: an international consensus. [europepmc]
• Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. [europepmc]
• Osteoporosis and sarcopenia in older age. [europepmc]
• Physical activity in older age: perspectives for healthy ageing and frailty. [europepmc]
• Exercise Promotes Healthy Aging of Skeletal Muscle. [europepmc]
• Pathogenesis and Management of Sarcopenia. [europepmc]
• Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms. [europepmc]
• Associations of Muscle Mass and Strength with All-Cause Mortality among US Older Adults. [europepmc]
• Sarcopenia: A Time for Action. An SCWD Position Paper. [europepmc]
• Aging and Imaging Assessment of Body Composition: From Fat to Facts. [europepmc]
• Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. [europepmc]
• Sarcopenia: A Contemporary Health Problem among Older Adult Populations. [europepmc]
• Sarcopenia in chronic kidney disease: what have we learned so far? [europepmc]
• A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors. [europepmc]
• Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. [europepmc]
• A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction. [europepmc]
• Biomarkers of aging. [europepmc]
• Sarcopenia and Cardiovascular Diseases. [europepmc]